Cardinal Health (CAH) Stock: Strong Earnings Guidance Offsets Mixed Quarter

TLDR

• Cardinal Health beat adjusted EPS estimates with $2.91 vs. the $2.42 expected
• Full-year adjusted EPS guidance of $12.40 to $12.60 topped the $12.08 Wall Street forecast
• Revenue rose 6% to $63.67 billion but missed the $65.15 billion analyst estimate
• Pharmaceutical segment revenue grew 6%; medical products and distribution fell 2%
• CAH stock dipped 0.8% in premarket trading Tuesday

Cardinal Health posted a mixed fiscal fourth quarter on Tuesday, but a strong full-year earnings outlook gave investors something to cheer about.

CARDINAL HEALTH $CAH Q4’26 EARNINGS HIGHLIGHTS

🔹 Revenue: $63.7B (Est. $65B) 🔴; +6% YoY
🔹 Adj. EPS: $2.91 (Est. $2.42) 🟢; +40% YoY
🔹 Non-GAAP Oper Earnings: $935M (Est. $820M) 🟢; +30% YoY
🔸 IEEPA Tariff Refund: $100M operating profit impact; $0.31 EPS impact

FY27 Guide:… pic.twitter.com/HbBlV1UQfE

- Wall St Engine (@wallstengine) August 11, 2026

Adjusted EPS came in at $2.91 for the quarter, beating the $2.42 analyst estimate. That figure included a 31-cent boost from tariff refunds, putting the underlying number at $2.60.

… Continue reading the full article at the original source below.